Abstract:Introduction: Lipoprotein(a) [Lp(a)] is a known risk factor for cardiovascular disease; however, its association with cerebrovascular disease is not as well established. Methods: Data from HCHS/SOL, a population-based cohort of Hispanics/Latinos, was utilized. We included 16,039 participants with measured Lp(a) levels (nmol/L) and self-reported history of prevalent stroke or transient-ischemic attack (TIA) from Visit 1. Data from SOL-INCA MRI (ancillary study conducted after Visit 2) was utilized to identify a subset of 2,668 HCHS/SOL participants with brain MRI. Linear and logistic regression was used to study the association of Lp(a) with 1. Self-reported stroke or TIA; 2. Cerebral injury defined as self-reported stroke or TIA or evidence of a stroke on brain MRI; and 3. White matter hyperintensity (WMH) volume modeled as log (WMH/total cranial volume). Lp(a) was modeled as a continuous variable and as quintiles. Sampling weights and surveys methods were used to account for the complex HCHS/SOL design. Results: HCHS/SOL mean age ± SE was 41.1 ± 0.3 years, 52.0% female, and median (IQR) Lp(a) level 19.7 (7.3-60.6) nmol/L. SOL-INCA MRI mean age ± SE was 49.9 ± 0.4 years, 56.4% female, and median (IQR) Lp(a) level 21.7 (8.1-62.9). A ten nmol/L unit increase in Lp(a) was significantly associated with a higher risk of self-reported prevalent stroke or TIA (OR 1.03, 95% CI: 1.02-1.05, p = 0.0002). Lp(a)>77 nmol/L (5 th quintile) was significantly associated with higher risk of self-reported prevalent stroke or TIA (OR 1.8, 95% CI: 1.2-2.8, p = 0.009) compared to Lp(a) <6 nmol/L (1 st quintile) as reference. A ten unit increase in Lp(a) was significantly associated with higher odds of cerebral injury (OR 1.03, 95% CI: 1.02-1.05, p 77 nmol/L was significantly associated with cerebral injury (OR 1.8, 95% CI 1.3- 2.6, p=0.002) as compared to Lp(a) <6 nmol/L. A ten unit increase in Lp(a) was also significantly associated with increasing WMH volume (β 0.02, p=0.0002). Conclusions: Lp(a) is significantly associated with self-reported prevalent stroke or TIA, brain MRI evidence of cerebral injury, and WMH, in a large diverse population of Hispanics/Latinos, suggesting that Lp(a) may be a modifiable risk factor for cerebrovascular disease.

A Polynesian-specific SLC22A3 variant associates with low plasma lipoprotein(a) concentrations independent of apo(a) isoform size in men

Genome- and exome-wide association study of serum lipoprotein (a) in the Jackson Heart Study

Functional Variant in the SLC22A3-LPAL2-LPA Gene Cluster Contributes to the Severity of Coronary Artery Disease

Single-Nucleotide Polymorphisms in Lpa Explain Most of the Ancestry-Specific Variation in Lp(A) Levels in African Americans

Lipoprotein(A) Levels And Genetic Polymorphisms In Lpa Genes May Contribute To Risk Of Coronary Heart Disease

SAA1 Gene Polymorphisms in Osteoporosis Patients

Variation in Lipoprotein(a) Response to Potent Lipid Lowering: The Role of Apolipoprotein (a) Isoform size

Erratum: A Rare Variant in APOC3 is Associated with Plasma Triglyceride and VLDL Levels in Europeans

Lack of Association Between Four SNPs in the SLC22A3-LPAL2-LPA Gene Cluster and Coronary Artery Disease in a Chinese Han Population: a Case Control Study

Abstract 11339: Relationship of LPA Single Nucleotide Polymorphisms with Apolipoprotein (a) Isoforms and Biomarkers of Oxidized Lipoproteins in African-Americans, Caucasians and Hispanics: Results from the DALLAS Heart Study

A Single Nucleotide Polymorphism in the FADS1 Gene is Associated with Plasma Fatty Acid and Lipid Profiles and Might Explain Gender Difference in Body Fat Distribution

LPA Gene, Ethnicity, and Cardiovascular Events.

Genetically predicted lipoprotein(a) associates with coronary artery plaque severity independent of low-density lipoprotein cholesterol

Association between lipoprotein(a) (Lp(a)) levels and Lp(a) genetic variants with coronary artery calcification

Lipoprotein (a):A Vital Member of Blood Lipid Items

Apolipoprotein(a) production and clearance are associated with plasma IL-6 and IL-18 levels, dependent on ethnicity

A Phenome-Wide Association Study of A Lipoprotein-Associated Phospholipase A(2) Loss-Of-Function Variant in 90 000 Chinese Adults

Abstract TMP102: Association of Lipoprotein(a) With Stroke and Cerebral Injury: Insights From the Hispanic Community Health Study/Study of Latinos (HCHS/SOL) and Investigation of Neurocognitive Aging-MRI (SOL-INCA MRI)

Association between SLC2A9 transporter gene variants and uric acid phenotypes in African American and white families

Impact of Lipoprotein(a) Level on Low-Density Lipoprotein Cholesterol- or Apolipoprotein B-Related Risk of Coronary Heart Disease

Factors Associated with Lipoprotein(a) Testing Among Multiethnic Individuals